One‐year outcomes of the ARTISAN‐SNM study with the Axonics System for the treatment of urinary urgency incontinence

Sacral neuromodulation (SNM) is a guideline‐recommended treatment for voiding dysfunction including urgency, urge incontinence, and nonobstructive retention as well as fecal incontinence. The Axonics® System is a miniaturized, rechargeable SNM system designed to provide therapy for at least 15 years, which is expected to significantly reduce revision surgeries as it will not require replacement as frequently as the non‐rechargeable SNM system. The ARTISAN‐SNM study is a pivotal study designed to treat patients with urinary urgency incontinence (UUI). Clinical results at 1‐year are presented.

[1]  U. Lee,et al.  Outcomes in a contemporary cohort undergoing sacral neuromodulation using optimized lead placement technique , 2019, Neurourology and urodynamics.

[2]  J. Hippisley-Cox,et al.  Anticholinergic Drug Exposure and the Risk of Dementia , 2019, JAMA internal medicine.

[3]  T. Kessler,et al.  Sacral neuromodulation using the standardized tined lead implantation technique with a curved vs a straight stylet: 2‐year clinical outcomes and sensory responses to lead stimulation , 2019, BJU international.

[4]  B. Blok,et al.  A prospective, multicenter study of a novel, miniaturized rechargeable sacral neuromodulation system: 12‐month results from the RELAX‐OAB study , 2019, Neurourology and urodynamics.

[5]  B. Blok,et al.  Treatment of Urinary Urgency Incontinence Using a Rechargeable SNM System: 6-month Results of the ARTISAN-SNM Study. , 2019, The Journal of urology.

[6]  K. Matzel,et al.  International Continence Society best practice statement for use of sacral neuromodulation , 2018, Neurourology and urodynamics.

[7]  D. Elterman,et al.  The novel Axonics® rechargeable sacral neuromodulation system: Procedural and technical impressions from an initial North American experience , 2018, Neurourology and urodynamics.

[8]  K. Matzel,et al.  Sacral Neuromodulation: Standardized Electrode Placement Technique , 2017, Neuromodulation : journal of the International Neuromodulation Society.

[9]  H. Goldman,et al.  Removal of Sacral Nerve Stimulation Devices for Magnetic Resonance Imaging: What Happens Next? , 2017, Neuromodulation : journal of the International Neuromodulation Society.

[10]  R. Dmochowski,et al.  Cost profiles and budget impact of rechargeable versus non‐rechargeable sacral neuromodulation devices in the treatment of overactive bladder syndrome , 2017, Neurourology and urodynamics.

[11]  M. Hudson,et al.  Clinical correlates of faecal incontinence in systemic sclerosis: identifying therapeutic avenues , 2016, Rheumatology.

[12]  C. Comiter,et al.  Results of a prospective, multicenter study evaluating quality of life, safety, and efficacy of sacral neuromodulation at twelve months in subjects with symptoms of overactive bladder , 2016, Neurourology and urodynamics.

[13]  H. Akram,et al.  Rechargeable occipital nerve stimulator systems: A patient satisfaction study , 2014, British journal of neurosurgery.

[14]  Joohi Jimenez-Shahed,et al.  Rechargeable Deep Brain Stimulation Implantable Pulse Generators in Movement Disorders: Patient Satisfaction and Conversion Parameters , 2014, Neuromodulation : journal of the International Neuromodulation Society.

[15]  Stephanie A. Jacobs,et al.  Randomized prospective crossover study of interstim lead wire placement with curved versus straight stylet , 2014, Neurourology and urodynamics.

[16]  Sean Nicholson,et al.  Global prevalence and economic burden of urgency urinary incontinence: a systematic review. , 2014, European urology.

[17]  C. Honey,et al.  Rechargeable Internal Neural Stimulators—Is There a Problem with Efficacy? , 2012, Neuromodulation : journal of the International Neuromodulation Society.

[18]  P. Abrams,et al.  Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction , 2011, BJU international.